| abstract |
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient; And modified pharmaceutically acceptable pharmaceutical compositions comprising a pharmaceutically acceptable diluent or carrier; And to such agents for use for the treatment of cardiovascular diseases:n n n n n n n n In the above formula, R 1 is C 1-2 alkyl substituted with one or more fluoro substituents; R 2 is hydrogen, hydroxy, methoxy or ethoxy; n is 0, 1 or 2; When the compound of formula (I) is in the form of a salt, the preparation may contain only yota-carrageenan and neutral colloidal polymers. |